Alcon CEO on where the company is headed following spin-off from Novartis
CFRA highlights Alcon's 'top position in eye care market', lifts share PT - Investing.com India
Novartis sees Alcon recovery opening door to spin-off IPO | Reuters
Novartis plans spinoff of Alcon, $5 billion share buyback - Market News | The Financial Express
Alcon Inc. - Registered Shares Shares Approach 52-Week High - Market Mover | Nasdaq
Nestle & Alcon | PDF | American Depositary Receipt | Valuation (Finance)
Alcon Debuts as Independent, Publicly Traded Company
Alcon closes Ivantis acquisition - MassDevice
Xiaomi prices its IPO; Deutsche stress; Novartis unloads Alcon
Nestlé and Alcon -case | PPT
Bausch & Lomb IPO Attracts Investors Amid Turbulence | Morningstar
Alcon Inc. (ALC) Company Profile & Overview - Stock Analysis
Here's Why We Think Alcon (VTX:ALC) Might Deserve Your Attention Today
Novartis weighs up IPO or spin-off of lossmaking eyecare division
Alcon Silver
Alcon: Global Leader In An Attractive End-Market (NYSE:ALC) | Seeking Alpha
Solved Alcon Metals just sold 20 million shares through an | Chegg.com
Barclays (NYSE:BCS) Reaches New 12-Month High at $9.57
Alcon's (ALC) Vivity EDOF IOL Achieves One Million Milestone | Nasdaq
Alcon: Lackluster Growth Given Its Valuation (NYSE:ALC) | Seeking Alpha
Alibaba shares spike in New York Stock Exchange debut - The Boston Globe
Novartis plans spinoff of Alcon, $5 billion share buy-back
ALC - Alcon Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NYSE)
ALC - Alcon Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NYSE)
Alcon - Crunchbase Company Profile & Funding
Alcon Turnaround Has Novartis Exploring Spin-off | Ophthalmology Innovation Source
